Vivani Medical, Inc. (VANI) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 6.66M USD | Liabilities, Current |
| Cash and equivalents | 19.89M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $6.66M | $19.89M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $6.78M | $19.75M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $6.60M | $16.23M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $6.83M | $2.63M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $6.72M | $6.79M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $6.20M | $13.01M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $5.99M | $18.35M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $6.27M | $19.65M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $5.78M | $24.92M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $6.14M | $29.65M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $5.72M | $20.65M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $7.43M | $24.82M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $7.09M | $32.49M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $5.86M | $38.07M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $6.82M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $5.62M | $51.68M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $2.59M | $56.38M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.38M | $59.60M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.46M | $69.59M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $3.92M | $72.03M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.66M | $73.84M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $6.94M | $26.86M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $5.13M | $3.18M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $2.98M | $2.44M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $2.72M | $3.50M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $5.22M | $2.34M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $6.96M | $11.33M | (m) | $455.00K | $1.03M | (m) |
| 2019-09-30 | (m) | $7.18M | $18.46M | (m) | $264.00K | $1.26M | (m) |
| 2019-06-30 | (m) | $7.84M | $25.16M | (m) | $629.00K | $1.47M | (m) |
| 2019-03-31 | (m) | $7.43M | $31.68M | (m) | $597.00K | $1.60M | (m) |
| 2018-12-31 | (m) | $7.60M | $4.47M | (m) | $504.00K | $3.25M | (m) |
| 2018-09-30 | (m) | $7.53M | $4.97M | (m) | $1.19M | $3.60M | (m) |
| 2018-06-30 | (m) | $7.07M | $7.48M | (m) | $718.00K | $3.57M | (m) |
| 2018-03-31 | (m) | $6.88M | (m) | (m) | $475.00K | $2.81M | (m) |
| 2017-12-31 | (m) | $6.62M | (m) | (m) | $1.83M | $2.70M | (m) |
| 2017-09-30 | (m) | $6.11M | (m) | (m) | $668.00K | $3.25M | (m) |
| 2017-06-30 | (m) | $5.46M | (m) | (m) | $926.00K | $3.05M | (m) |
| 2017-03-31 | (m) | $5.76M | (m) | (m) | $782.00K | $3.12M | (m) |
| 2016-12-31 | (m) | $5.66M | (m) | (m) | $274.00K | $3.42M | (m) |
| 2016-09-30 | (m) | $5.67M | (m) | (m) | $447.00K | $5.81M | (m) |
| 2016-06-30 | (m) | $6.03M | (m) | (m) | $677.00K | $7.37M | (m) |
| 2016-03-31 | (m) | $6.62K | $459.00 | (m) | $822.00 | $9.08K | (m) |
| 2015-12-31 | (m) | $7.98M | $239.00K | (m) | $1.50M | $8.21M | (m) |
| 2015-09-30 | (m) | $8.78M | $268.66K | (m) | $1.31M | $8.14M | (m) |
| 2015-06-30 | (m) | $8.84M | $407.44K | (m) | $1.21M | $6.81M | (m) |
| 2015-03-31 | (m) | $9.00M | $652.25K | (m) | $1.30M | $6.40M | (m) |
| 2014-12-31 | (m) | $8.45M | $619.41K | (m) | $707.65K | $5.72M | (m) |
| 2014-09-30 | (m) | (m) | $977.40K | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $2.95M | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | $452.57K | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $62.56K | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $145.00K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |